Quinoline as TRPV1 Antagonists: A New Approach against Inflammation

  • Megha P. Ambatkar
  • Pramod B. Khedekar

Abstract

Inflammation is the first response of the immune system to harmful stimuli such as infection or irritation, consists of a cascade of biochemical events that propagates and matures the inflammatory response. Number of anti-inflammatory drugs are available for treatment of acute and chronic inflammation. Many anti-inflammatory drugs cause adverse side effects. The quinoline class of compounds are important for searching the safe and effective anti-inflammatory drugs. These drugs are classified based on the number of substituents present on the quinoline ring or compounds containing a quinoline ring fused to other heterocyclic compounds. Quinolines have the ability to target several causes of inflammation includes transient receptor potential vanilloid 1 receptor. The TRPV1 receptor, first cloned and characterized in 1997, is a non-selective cation channel expressed in primary sensory neurons, and is a key pain sensor and integrator. This review provides the discovery of various quinoline derivatives as transient receptor potential vanilloid 1 (TRPV1) antagonists. Overall, the quinoline moiety will be used as a new template for designing and identifying the novel anti-inflammatory drugs in future.


Keywords: Quinoline, Inflammation, Transient receptor Potential Vanilloid 1, Antagonists.

Downloads

Download data is not yet available.

Author Biographies

Megha P. Ambatkar

Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur- 440 033. Maharashtra, India

Pramod B. Khedekar

Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur- 440 033. Maharashtra, India

Statistics
272 Views | 253 Downloads
How to Cite
1.
Ambatkar MP, Khedekar PB. Quinoline as TRPV1 Antagonists: A New Approach against Inflammation. JDDT [Internet]. 25Aug.2019 [cited 18Jun.2021];9(4-s):782-8. Available from: https://jddtonline.info/index.php/jddt/article/view/3414